[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349252-105":59,"doc-detail-349252-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","immunohistochemical-evaluation-of-glutaminase-1-enzyme-in-oral-squamous-cell-carcinoma","Immunohistochemical evaluation of glutaminase-1 enzyme in oral squamous cell carcinoma","","Immunohistochemical expression of glutaminase-1 (GLS1) was assessed to characterize metabolic reprogramming in oral squamous cell carcinoma (OSCC). A retrospective cohort of 98 formalin-fixed, paraffin-embedded OSCC samples was analyzed using immunohistochemical GLS1 scoring for intensity and extent, alongside evaluation of tumour-infiltrating lymphocytes and clinicopathological parameters. GLS1 immunointensity and immunoextent showed statistically significant association with worsening OSCC grades and the GLS1 immunoscore. No significant relationship was detected between TNM staging or tumour-infiltrating lymphocytes and GLS1 immunoscore.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immunohistochemical-evaluation-of-glutaminase-1-enzyme-in-oral-squamous-cell-carcinoma/349252/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immunohistochemical-evaluation-of-glutaminase-1-enzyme-in-oral-squamous-cell-carcinoma/349252.png","ImageObject",300,407,{"name":92,"@type":93},"eBook King","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study aiming to evaluate regarding GLS1 in OSCC?","Question",{"text":113,"@type":114},"The study evaluated the intensity and extent of GLS1 immunohistochemical expression across OSCC grades and examined associations with staging, grading, and tumour infiltrating lymphocytes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was GLS1 expression measured in the OSCC samples?",{"text":118,"@type":114},"GLS1 expression was assessed immunohistochemically, comparing intensity and extent to generate a GLS1 immunoscore.",{"name":120,"@type":111,"acceptedAnswer":121},"What relationships did the study find between GLS1 immunoscore and OSCC progression?",{"text":122,"@type":114},"GLS1 immunointensity and immunoextent were significantly associated with the GLS1 immunoscore and with worsening OSCC grades.",{"name":124,"@type":111,"acceptedAnswer":125},"Did TNM staging or tumour-infiltrating lymphocytes correlate with GLS1 immunoscore?",{"text":126,"@type":114},"No significant association was reported between TNM staging or tumour-infiltrating lymphocytes and the GLS1 immunoscore.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},349252,1790182441,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":46,"preview_page_count":19,"preview_urls":149},962088006270,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Indian J Med Res 163, May 2026, pp 585-592 DOI: 10.25259/IJMR_2652_2025  \nOriginal Article  \nImmunohistochemical evaluation of glutaminase-1 enzyme in oralsquamous cell carcinoma  \nMadhuri Shital Chougule,1 B.R. Patil,3 Vijayalakshmi S. Kotrashetti,4 Priya S. Joshi, 1 Ashwini Mane Patil2 and Suraj B. Pawar\\#  \n1Department of Oral Pathology and Microbiology, Vasantdada Patil Dental College and Hospital, Sangli, 2Department of Pathology, \\#Kolhapur Cancer Center, Gokul Shirgaon, Maharashtra, 3Karnataka Cancer Therapy and Research Institute, Hubballi and 4Department of Oral Pathology and Microbiology, Maratha Mandal’s Nathajirao G. Halgekar Institute of Dental Sciences, Belgavi, Karnataka, India  \nReceived September 26, 2025; Accepted December 4, 2025; Published May 16, 2026  \nBackground and objectives: Malignant cells reprogram their metabolism. Glutamine is a major biosynthetic precursor apart from glucose in various cancers. Glutaminase 1 (kidney type) is the rate limiting enzyme in glutamine metabolism, which is increased in cancers of prostate, breast, colorectum, ovary and oral squamous cell. We aimed to evaluate the intensity and extent of immunohistochemical expression of glutaminase1 in various grades of oral squamous cell carcinoma (OSCC) and investigate whether any association exists between the glutaminase 1expression with staging, grading and tumour infiltrating lymphocytes.  \nMethods: This retrospective analysis included 98 formalin-fixed, paraffin-embedded tissue blocks of clinically and histopathologically confirmed cases of OSCC. One section was stained with haematoxylin and eosin and the other, immunohistochemically for glutaminase 1(GLS1) . Staging, grading, tumour infiltrating lymphocytes were evaluated for their relation with GLS1 immunoscore.  \nResults: Statistically significant association was noted between GLS1 immunointensity (P\u003C0.001) immunoextent (P\u003C0.001) and the immunoscore (P=0.007) with the worsening grades of OSCC. There was no significant association between TNM staging P\u003C0.61) and tumour infiltrating lymphocytes with GLS1 immunoscore (P=0.30) .  \nInterpretation and conclusions: Glutaminase 1 expression increases with worsening grade of OSCC signifying an altered metabolic phenotype as the cancer cells lose differentiation.  \nKeywords Cancer metabolism; Glutaminase 1 expression; Oral squamous cell carcinoma; TNM staging; Tumour grade; Tumour infiltrating lymphocytes  \nCancer is a disease of cell proliferation. Metabolic reprogramming is one of the hallmarks of cancer. Glucose-independent glutamine metabolism via the tricarboxylic acid (TCA) cycle is essential for malignant cell proliferation and survival within hypoxicand nutrient-depleted tumour microenvironments.1 Glutamine is a conditionally essential amino acid; an important nutrient source for cancer tissues and is studied in numerous cancers.1-5 Glutamine is also required for growth, autophagy, signal transduction, immune function, acid-base balance, radio resistance, to regulate gene expression, mitogen-activated protein kinase activation and for regulating glucose  \nuptake. 1-3,6,7 It also supplies nitrogen for synthesis of purine, pyrimidine and nonessential amino acids.2 Some cancers develop a reliance on glutamine and are referred to as, ‘glutamine addicted’.2 These tumours over express the enzyme glutaminase (GLS) which is involved in the first step of glutaminolysis and converts glutamine to glutamate.2,8 There are two isoenzymes, GLS1; kidney-type isoenzyme (KGA), and GLS 2; the liver-type isoform (LGA) .8 The activity of GLS1 controls the flux of glutaminolysis.3 GLS1 is found tobe increased in numerous cancers, and this metabolic phenotype is associated with a higher disease stage and poor prognosis.4,5,8,9  \nHow to cite this article: Chougule MS, Patil BR, Kotrashetti VS, Joshi PS, Patil AM, Pawar SB, et al. Immunohistochemical evaluation of glutaminase-1 enzyme in oral squamous cell carcinoma. Indian J Med Res. 2026;163:585-92 . ","cbCainNbdDt0Xfgq","https://ap.wps.com/l/cbCainNbdDt0Xfgq","pdf",1106460,"English","# Background and Objectives\n# Methods\n# Results\n# Interpretation and Conclusions","[{\"question\":\"What was the study aiming to evaluate regarding GLS1 in OSCC?\",\"answer\":\"The study evaluated the intensity and extent of GLS1 immunohistochemical expression across OSCC grades and examined associations with staging, grading, and tumour infiltrating lymphocytes.\"},{\"question\":\"How was GLS1 expression measured in the OSCC samples?\",\"answer\":\"GLS1 expression was assessed immunohistochemically, comparing intensity and extent to generate a GLS1 immunoscore.\"},{\"question\":\"What relationships did the study find between GLS1 immunoscore and OSCC progression?\",\"answer\":\"GLS1 immunointensity and immunoextent were significantly associated with the GLS1 immunoscore and with worsening OSCC grades.\"},{\"question\":\"Did TNM staging or tumour-infiltrating lymphocytes correlate with GLS1 immunoscore?\",\"answer\":\"No significant association was reported between TNM staging or tumour-infiltrating lymphocytes and the GLS1 immunoscore.\"}]","Immunohistochemical evaluation of glutaminase-1 enzyme in oral squamous cell carcinoma | PDF",1790082442,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d04db14b2e433b943cb5ca97a424710.webp",983,1272,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c1552c6cd8fdd118d4306313c754a08.webp",982,1270,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd42e926b2081eb72d2d797f44f59ab2.webp",981,1269,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb673c650fa63971674001dff2aabaf6.webp",980,1268]